{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:24:54Z","timestamp":1791602694904,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010804","name":"Faculty of Medicine, Prince of Songkla University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-70526-z","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:14:17Z","timestamp":1724411657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Changes in the epidemiological trends of primary liver cancer in the Asia\u2013Pacific region"],"prefix":"10.1038","volume":"14","author":[{"given":"Pojsakorn","family":"Danpanichkul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanokphong","family":"Suparan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banthoon","family":"Sukphutanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuthathip","family":"Kaeosri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primrose","family":"Tothanarungroj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supapitch","family":"Sirimangklanurak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markos","family":"Kalligeros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natchaya","family":"Polpichai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karn","family":"Wijarnpreecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pimsiri","family":"Sripongpun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naichaya","family":"Chamroonkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindie H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suthat","family":"Liangpunsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teerha","family":"Piratvisuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apichat","family":"Kaewdech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"issue":"1","key":"70526_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers. 7(1), 6 (2021).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"70526_CR2","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2147\/OTT.S93629","volume":"10","author":"S Buettner","year":"2017","unstructured":"Buettner, S., van Vugt, J. L., IJzermans, J. N. & Groot Koerkamp, B. Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther. 10, 1131\u201342 (2017).","journal-title":"Onco Targets Ther."},{"issue":"4","key":"70526_CR3","first-page":"201","volume":"38","author":"SF Altekruse","year":"2011","unstructured":"Altekruse, S. F., Devesa, S. S., Dickie, L. A., McGlynn, K. A. & Kleiner, D. E. Histological classification of liver and intrahepatic bile duct cancers in SEER registries. J. Regist. Manag. 38(4), 201\u2013205 (2011).","journal-title":"J. Regist. Manag."},{"issue":"6","key":"70526_CR4","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay, H. et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J. Hepatol. 77(6), 1598\u20131606 (2022).","journal-title":"J. Hepatol."},{"issue":"Supp 1","key":"70526_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn, K. A., Petrick, J. L. & El-Serag, H. B. Epidemiology of hepatocellular carcinoma. Hepatology. 73(Supp 1), 4\u201313 (2021).","journal-title":"Hepatology."},{"issue":"11","key":"70526_CR6","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1080\/17474124.2021.1991792","volume":"15","author":"P Konyn","year":"2021","unstructured":"Konyn, P., Ahmed, A. & Kim, D. Current epidemiology in hepatocellular carcinoma. Expert Rev. Gastroenterol. Hepatol. 15(11), 1295\u20131307 (2021).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"70526_CR7","unstructured":"Asia-Pacific Population and Development Report 2023. Bangkok: Social Development Division, Economic and Social Commission for Asia and the Pacific (ESCAP), United Nations (2023)."},{"issue":"4","key":"70526_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101020","volume":"6","author":"P Danpanichkul","year":"2024","unstructured":"Danpanichkul, P. et al. Global and regional burden of alcohol-associated liver disease and alcohol use disorder in the elderly. JHEP Rep. 6(4), 101020 (2024).","journal-title":"JHEP Rep."},{"issue":"20","key":"70526_CR9","doi-asserted-by":"publisher","first-page":"6456","DOI":"10.3390\/jcm12206456","volume":"12","author":"P Danpanichkul","year":"2023","unstructured":"Danpanichkul, P. et al. The surreptitious burden of nonalcoholic fatty liver disease in the elderly in the asia-pacific region: An insight from the global burden of disease study 2019. J. Clin. Med. 12(20), 6456 (2023).","journal-title":"J. Clin. Med."},{"issue":"10","key":"70526_CR10","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/apt.17714","volume":"58","author":"P Danpanichkul","year":"2023","unstructured":"Danpanichkul, P. et al. The silent burden of non-alcoholic fatty liver disease in the elderly: A global burden of disease analysis. Aliment. Pharmacol. Ther. 58(10), 1062\u20131074 (2023).","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"70526_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101020","volume":"6","author":"P Danpanichkul","year":"2024","unstructured":"Danpanichkul, P. et al. Global and regional burden of alcohol-associated liver disease and alcohol use disorder in the elderly. JHEP Rep. 6(4), 101020 (2024).","journal-title":"JHEP Rep."},{"issue":"11","key":"70526_CR12","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.31557\/APJCP.2022.23.11.3701","volume":"23","author":"T Kitiyakara","year":"2022","unstructured":"Kitiyakara, T. et al. Regional differences in admissions and treatment outcomes for hepatocellular carcinoma patients in Thailand. Asian Pac. J. Cancer Prev. 23(11), 3701\u20133715 (2022).","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"6","key":"70526_CR13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.21147\/j.issn.1000-9604.2018.06.01","volume":"30","author":"R Zheng","year":"2018","unstructured":"Zheng, R. et al. Liver cancer incidence and mortality in China: Temporal trends and projections to 2030. Chin. J. Cancer Res. 30(6), 571\u2013579 (2018).","journal-title":"Chin. J. Cancer Res."},{"issue":"9","key":"70526_CR14","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"GBDHB Collaborators","year":"2022","unstructured":"Collaborators, G. B. D. H. B. Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol. Hepatol. 7(9), 796\u2013829 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"10258","key":"70526_CR15","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"GBDRF Collaborators","year":"2020","unstructured":"Collaborators, G. B. D. R. F. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 396(10258), 1223\u201349 (2020).","journal-title":"Lancet."},{"issue":"5","key":"70526_CR16","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/cam4.4551","volume":"11","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019. Cancer Med. 11(5), 1310\u20131323 (2022).","journal-title":"Cancer Med."},{"issue":"10258","key":"70526_CR17","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD Diseases","year":"2020","unstructured":"Diseases, G. B. D. & Injuries, C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 396(10258), 1204\u20131222 (2020).","journal-title":"Lancet."},{"issue":"7","key":"70526_CR18","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","volume":"34","author":"DQ Huang","year":"2022","unstructured":"Huang, D. Q. et al. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 34(7), 969\u201377.e2 (2022).","journal-title":"Cell Metab."},{"issue":"2","key":"70526_CR19","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","volume":"80","author":"SJ Song","year":"2024","unstructured":"Song, S. J., Lai, J. C., Wong, G. L., Wong, V. W. & Yip, T. C. Can we use old NAFLD data under the new MASLD definition?. J. Hepatol. 80(2), e54\u2013e56 (2024).","journal-title":"J. Hepatol."},{"issue":"5","key":"70526_CR20","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","volume":"80","author":"ZM Younossi","year":"2024","unstructured":"Younossi, Z. M. et al. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease. J. Hepatol. 80(5), 694\u2013701 (2024).","journal-title":"J. Hepatol."},{"key":"70526_CR21","doi-asserted-by":"crossref","unstructured":"Suzuki, H., Tsutsumi, T., Kawaguchi, M., Amano, K., Kawaguchi, T. Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia. Clin. Mol. Hepatol. (2024).","DOI":"10.3350\/cmh.2024.0264"},{"issue":"2","key":"70526_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2023.101320","volume":"14","author":"P Danpanichkul","year":"2024","unstructured":"Danpanichkul, P. et al. The global burden of early-onset biliary tract cancer: Insight from the global burden of disease study 2019. J. Clin. Exp. Hepatol. 14(2), 101320 (2024).","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"12","key":"70526_CR23","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1111\/jgh.16331","volume":"38","author":"P Danpanichkul","year":"2023","unstructured":"Danpanichkul, P. et al. Rising incidence and impact of early-onset colorectal cancer in the Asia-Pacific with higher mortality in females from Southeast Asia: A global burden analysis from 2010 to 2019. J. Gastroenterol. Hepatol. 38(12), 2053\u20132060 (2023).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"70526_CR24","unstructured":"Danpanichkul, P., Ng, C. H., Hao Tan, D. J., Wijarnpreecha, K., Huang, D. Q., Noureddin, M., et al. The global burden of alcohol-associated cirrhosis and cancer in young and middle-aged adults. Clin. Gastroenterol. Hepatol. (2024)."},{"key":"70526_CR25","doi-asserted-by":"crossref","unstructured":"LaPelusa, M., Shen, C., Arhin, N. D., Cardin, D., Tan, M., Idrees, K., et al. Trends in the incidence and treatment of early-onset pancreatic Cancer. Cancers (Basel). 14(2) (2022).","DOI":"10.3390\/cancers14020283"},{"issue":"2","key":"70526_CR26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s44197-023-00109-0","volume":"13","author":"G Cao","year":"2023","unstructured":"Cao, G., Liu, J. & Liu, M. Global, regional, and national trends in incidence and mortality of primary liver cancer and its underlying etiologies from 1990 to 2019: Results from the global burden of disease study 2019. J. Epidemiol. Glob. Health. 13(2), 344\u2013360 (2023).","journal-title":"J. Epidemiol. Glob. Health."},{"issue":"3","key":"70526_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cgh.2022.03.010","volume":"21","author":"MA Karim","year":"2023","unstructured":"Karim, M. A. et al. Clinical characteristics and outcomes of nonalcoholic fatty liver disease-associated hepatocellular carcinoma in the United States. Cli. Gastroenterol. Hepatol. 21(3), 670-680.e18 (2023).","journal-title":"Cli. Gastroenterol. Hepatol."},{"issue":"9959","key":"70526_CR28","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Trepo","year":"2014","unstructured":"Trepo, C., Chan, H. L. & Lok, A. Hepatitis B virus infection. Lancet. 384(9959), 2053\u20132063 (2014).","journal-title":"Lancet."},{"key":"70526_CR29","doi-asserted-by":"publisher","first-page":"1334160","DOI":"10.3389\/fphar.2023.1334160","volume":"14","author":"A Nawaz","year":"2023","unstructured":"Nawaz, A. et al. Therapeutic approaches for chronic hepatitis C: A concise review. Front. Pharmacol. 14, 1334160 (2023).","journal-title":"Front. Pharmacol."},{"issue":"9","key":"70526_CR30","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.mayocp.2023.02.009","volume":"98","author":"P Sripongpun","year":"2023","unstructured":"Sripongpun, P. et al. Hepatitis C screening in post-baby boomer generation Americans: one size does not fit all. Mayo Clin. Proc. 98(9), 1335\u20131344 (2023).","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"70526_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.27120","volume":"60","author":"AS Lok","year":"2014","unstructured":"Lok, A. S. Progress in hepatitis B: A 30-year journey through three continents. Hepatology. 60(1), 4\u201311 (2014).","journal-title":"Hepatology."},{"issue":"3","key":"70526_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40272-017-0229-1","volume":"19","author":"N Chamroonkul","year":"2017","unstructured":"Chamroonkul, N. & Piratvisuth, T. Hepatitis B during pregnancy in endemic areas: Screening, treatment, and prevention of mother-to-child transmission. Paediatr. Drugs. 19(3), 173\u2013181 (2017).","journal-title":"Paediatr. Drugs."},{"issue":"2","key":"70526_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","volume":"5","author":"SK Sarin","year":"2020","unstructured":"Sarin, S. K. et al. Liver diseases in the Asia-Pacific region: A lancet gastroenterology & hepatology commission. Lancet Gastroenterol. Hepatol. 5(2), 167\u2013228 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"4","key":"70526_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2471\/BLT.12.107318","volume":"91","author":"YL Tang","year":"2013","unstructured":"Tang, Y. L. et al. Alcohol and alcohol-related harm in China: Policy changes needed. Bull. World Health Organ. 91(4), 270\u2013276 (2013).","journal-title":"Bull. World Health Organ."},{"issue":"1","key":"70526_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12889-017-4041-1","volume":"17","author":"P Ranasinghe","year":"2017","unstructured":"Ranasinghe, P., Mathangasinghe, Y., Jayawardena, R., Hills, A. P. & Misra, A. Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: A systematic review. BMC Public Health. 17(1), 101 (2017).","journal-title":"BMC Public Health."},{"issue":"6","key":"70526_CR36","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.14309\/ajg.0000000000002819","volume":"119","author":"P Danpanichkul","year":"2024","unstructured":"Danpanichkul, P. et al. The burden of overweight and obesity-associated gastrointestinal cancers in low and lower-middle-income countries: A global burden of disease 2019 analysis. Am. J. Gastroenterol. 119(6), 1177\u20131180 (2024).","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"70526_CR37","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","volume":"76","author":"JV Lazarus","year":"2022","unstructured":"Lazarus, J. V. et al. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?. J. Hepatol. 76(4), 771\u2013780 (2022).","journal-title":"J. Hepatol."},{"issue":"5","key":"70526_CR38","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1002\/hep.32016","volume":"74","author":"LA Diaz","year":"2021","unstructured":"Diaz, L. A. et al. Impact of public health policies on alcohol-associated liver disease in Latin America: An ecological multinational study. Hepatology. 74(5), 2478\u20132490 (2021).","journal-title":"Hepatology."},{"issue":"3","key":"70526_CR39","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jhep.2023.11.006","volume":"80","author":"LA Diaz","year":"2024","unstructured":"Diaz, L. A. et al. Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes. J. Hepatol. 80(3), 409\u2013418 (2024).","journal-title":"J. Hepatol."},{"key":"70526_CR40","doi-asserted-by":"crossref","unstructured":"Danpanichkul, P., Duangsonk, K., Diaz, L. A., Arab, J. P., Liangpunsakul, S., Wijarnpreecha, K. Editorial: Sounding the alarm-The rising global burden of adolescent and young adult alcohol-related liver disease. Author's reply. Aliment. Pharmacol. Ther. (2024).","DOI":"10.1111\/apt.18157"},{"key":"70526_CR41","doi-asserted-by":"crossref","unstructured":"Zeng, R. W., Ong, C. E. Y., Ong, E. Y. H., Chung, C. H., Lim, W. H., Xiao, J., Danpanichkul, P., Law, J. H., Syn, N., Chee, D., Kow, A. W. C., Lee, S. W, Takahashi, H., Kawaguchi, T., Tamaki, N., Dan, Y. Y, Nakajima, A., Wijarnpreecha, K., Muthiah, M. D, Noureddin, M, Loomba, R., Ioannou, G. N., Tan, D. J. H., Ng, C. H., Huang, D. Q. Global prevalence, clinical characteristics, surveillance, treatment allocation, and outcomes of alcohol-associated hepatocellular carcinoma. Clin. Gastroenterol. Hepatol. (2024).","DOI":"10.1016\/j.cgh.2024.06.026"},{"issue":"4","key":"70526_CR42","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","volume":"23","author":"DJH Tan","year":"2022","unstructured":"Tan, D. J. H. et al. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis. Lancet Oncol. 23(4), 521\u2013530 (2022).","journal-title":"Lancet Oncol."},{"key":"70526_CR43","doi-asserted-by":"crossref","unstructured":"Israelsen, M., Rungratanawanich, W., Thiele, M., Liangpunsakul, S. Non-invasive tests for alcohol-associated liver disease. Hepatology. (2024).","DOI":"10.1097\/HEP.0000000000000885"},{"key":"70526_CR44","doi-asserted-by":"crossref","unstructured":"Preechathammawong, N., Charoenpitakchai, M., Wongsason, N., Karuehardsuwan, J., Prasoppokakorn, T., Pitisuttithum, P., et al. Development of a diagnostic support system for the fibrosis of nonalcoholic fatty liver disease using artificial intelligence and deep learning. Kaohsiung J. Med. Sci. (2024).","DOI":"10.1002\/kjm2.12850"},{"key":"70526_CR45","doi-asserted-by":"crossref","unstructured":"Danpanichkul, P., Aboona, M. B., Sukphutanan, B., Kongarin, S., Duangsonk, K., Ng, C. H., et al. Incidence of liver cancer in young adults according to the global burden of disease database 2019. Hepatology. (2024).","DOI":"10.1097\/HEP.0000000000000872"},{"issue":"5\u20136","key":"70526_CR46","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/0898264318824180","volume":"32","author":"A Balachandran","year":"2020","unstructured":"Balachandran, A., de Beer, J., James, K. S., van Wissen, L. & Janssen, F. Comparison of population aging in Europe and Asia using a time-consistent and comparative aging measure. J. Aging Health. 32(5\u20136), 340\u2013351 (2020).","journal-title":"J. Aging Health."},{"issue":"1","key":"70526_CR47","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4251\/wjgo.v14.i1.230","volume":"14","author":"CW Wu","year":"2022","unstructured":"Wu, C. W. & Lui, R. N. Early-onset colorectal cancer: Current insights and future directions. World J. Gastrointest. Oncol. 14(1), 230\u2013241 (2022).","journal-title":"World J. Gastrointest. Oncol."},{"issue":"2","key":"70526_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4251\/wjgo.v2.i2.59","volume":"2","author":"AN Milne","year":"2010","unstructured":"Milne, A. N. & Offerhaus, G. J. Early-onset gastric cancer: Learning lessons from the young. World J. Gastrointest. Oncol. 2(2), 59\u201364 (2010).","journal-title":"World J. Gastrointest. Oncol."},{"issue":"3","key":"70526_CR49","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s10903-021-01142-6","volume":"23","author":"HT Nguyen","year":"2021","unstructured":"Nguyen, H. T., Zheng, A., Gugel, A. & Kistin, C. J. Asians and Asian subgroups are underrepresented in medical research studies published in high-impact generalist journals. J. Immigr. Minor. Health. 23(3), 646\u2013649 (2021).","journal-title":"J. Immigr. Minor. Health."},{"key":"70526_CR50","first-page":"55","volume":"9","author":"FH Alhashimi","year":"2018","unstructured":"Alhashimi, F. H., Khabour, O. F., Alzoubi, K. H. & Al-Shatnawi, S. F. Attitudes and beliefs related to reporting alcohol consumption in research studies: a case from Jordan. Pragmat. Obs. Res. 9, 55\u201361 (2018).","journal-title":"Pragmat. Obs. Res."},{"issue":"3","key":"70526_CR51","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S2468-1253(23)00443-0","volume":"9","author":"M Israelsen","year":"2024","unstructured":"Israelsen, M. et al. Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study. Lancet Gastroenterol. Hepatol. 9(3), 218\u2013228 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"70526_CR52","doi-asserted-by":"crossref","unstructured":"Danpanichkul, P., Suparan, K., Kim, D., Wijarnpreecha, K. What is new in metabolic dysfunction-associated steatotic liver disease in lean individuals: From bench to bedside. J. Clin. Med. 13(1) (2024).","DOI":"10.3390\/jcm13010278"},{"key":"70526_CR53","doi-asserted-by":"crossref","unstructured":"Hagstrom, H., Adams, L. A., Allen, A. M., Byrne, C. D., Chang, Y., Duseja, A., et al. The future of international classification of diseases coding in steatotic liver disease: An expert panel Delphi consensus statement. Hepatol. Commun. 8(2) (2024).","DOI":"10.1097\/HC9.0000000000000386"},{"issue":"3","key":"70526_CR54","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.suc.2020.02.013","volume":"100","author":"JC Mejia","year":"2020","unstructured":"Mejia, J. C. & Pasko, J. Primary liver cancers: Intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Surg. Clin. North Am. 100(3), 535\u2013549 (2020).","journal-title":"Surg. Clin. North Am."},{"issue":"3","key":"70526_CR55","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/apt.18101","volume":"60","author":"P Danpanichkul","year":"2024","unstructured":"Danpanichkul, P. et al. Global epidemiology of alcohol-associated liver disease in adolescents and young adults. Aliment Pharmacol. Ther. 60(3), 378\u2013388. https:\/\/doi.org\/10.1111\/apt.18101 (2024).","journal-title":"Aliment Pharmacol. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70526-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:33:48Z","timestamp":1724412828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70526-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["70526"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-70526-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"24 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Teerha Piratvisuth received research grants from Gilead Sciences, Roche Diagnostics, Janssen, Fibrogen, and VIR and honoraria from Bristol-Myers Squibb, Gilead Sciences, Bayer, Abbott, Esai, Mylan, Ferring, and MSD. Mindie H. Nguyen received research support from Pfizer, Enanta, Astra Zeneca, GSK, Delfi, Innogen, Exact Science, CurveBio, Gilead, Vir Biotech, Helio Health, National Cancer Institute, Glycotest, National Health Institute and is a consultant and\/or advisory board of GSK, Gilead, and Exelixis. Dr. Liangpunsakul discloses consulting roles with Durect Corporation, Surrozen, and Korro Bio. However, these roles do not present any conflict of interest concerning the content of this work. Apichat Kaewdech received research grants or support from Roche, Roche Diagnostics, and Abbott Laboratories, and honoraria from Roche, Roche Diagnostics, Abbott Laboratories, and Esai. The other authors have no relevant conflict of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19544"}}